56 -9 (83) 2025 - Rakhimov O.U., Khamdamov B.Z. - IMMUNOLOGICAL COMPENSATION IN DISSEMINATED PERITONITIS

IMMUNOLOGICAL COMPENSATION IN DISSEMINATED PERITONITIS

Rakhimov O.U. - Tashkent State Medical University

Khamdamov B.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Dadaev Sh.A. - Tashkent State Medical University

Resume

The proposed immunoprophylaxis algorithm demonstrates a systemic effect on key links of the immune response in peritonitis, restores coordination between T-cell, humoral and mediator mechanisms, reduces inflammatory and antigen pressure, which ensures the transition of the disease from the destabilized phase to a controlled and manageable one.

Key words: disseminated peritonitis, complication, immunoprophylaxis.

First page

347

Last page

354

For citation:Rakhimov O.U., Khamdamov B.Z., Dadaev Sh.A. - IMMUNOLOGICAL COMPENSATION IN DISSEMINATED PERITONITIS//New Day in Medicine 9(83)2025 347-354 https://newdayworldmedicine.com/en/new_day_medicine/9-83-2025

List of References

  1. Акперов И.А., Бутенко Ю.А., Гуцуляк А.И. Многоэтапные операции в лечении разлитого гнойного перитонита // Фундаментальные и прикладные исследования в современном мире. 2019;25:28-31. — EDN YYHMIP.
  2. Ашурметов А.М., Жафаров Х.М., Ахмедов М.Д., и др. Лимфоиммунностимуляция при разлитом гнойном перитоните // Молодой ученый. 2018;7(193):103-105. — EDN YPPKUY
  3. Битюков С.Л., Демиденко В.В. Эффективность использования Мангеймского индекса перитонита в прогнозировании осложнений и летальности при разлитом перитоните // Морфологический альманах имени В.Г. Ковешникова. 2019;17(3):14-18. — EDN KLNKHX.
  4. Мильдзихов Г.У., Пагиева М.К., Перисаева Э.А. Комплексное лечение больных с разлитым перитонитом и методы профилактики его осложнений // Новое в хирургии, анестезиологии и реаниматологии. 2015; 69-71 стр. — EDN TBBXLN
  5. Ackley R., Roshdy D., Meredith J., et al. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae infections // Antimicrobial Agents and Chemotherapy. 2020;64(5):Article e02313-19. DOI: 10.1128/AAC.02313-19.
  6. Alosaimy S., Jorgensen S.C.J., Lagnf A.M., et al. Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections // Open Forum Infectious Diseases. 2020;7(3):Article ofaa051. DOI: 10.1093/ofid/ofaa051.
  7. Bavaro D.F., Papagni R., Belati A., et al. Cefiderocol versus colistin for the treatment of carbapenem-resistant Acinetobacter baumannii complex bloodstream infections: a retrospective, propensity-score adjusted monocentric cohort study // Infectious Diseases and Therapy. 2023;12(8):2147-2163. DOI: 10.1007/s40121-023-00854-6.
  8. Coccolini F., Sartelli M., Sawyer R., et al. Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines // World J Emerg Surg. 2023;18(1):Article41. DOI: 10.1186/s13017-023-00509-4
  9. De Pascale G., Posteraro B., D’Arrigo S., et al. (1,3)-β-D-glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial // Critical Care. 2020;24(1):Article 550. DOI: 10.1186/s13054-020-03265-y
  10. De Waele J.J., Girardis M., Martin-Loeches I. Source control in the management of sepsis and septic shock // Intensive Care Med. 2022;48(12):1799-1802. DOI: 10.1007/s00134-022-06852-5
  11. Eichel V.M., Greenberg J.A., Trzeciak S., et al. Early immune signatures in patients with sepsis: from pathogenesis to clinical stratification // Critical Care. 2023;27(1):Article45. DOI: 10.1186/s13054-023-04318-2
  12. Eichel V.M., Last K., Brühwasser C., et al. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis // Journal of Hospital Infection. 2023;141:119-128. DOI: 10.1016/j.jhin.2023.09.008.

    file

    download